Shuttle Pharmaceuticals Stock Analysis

Shuttle Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Shuttle Pharmaceuticals recorded a loss per share of 0.47. The entity had not issued any dividends in recent years. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. The company was founded in 2012 and is based in Rockville, Maryland. Shuttle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To find out more about Shuttle Pharmaceuticals contact the company at 240 403 4212 or learn more at https://www.shuttlepharma.com.

Shuttle Pharmaceuticals Investment Alerts

Shuttle Pharmaceuticals Upcoming and Recent Events

Shuttle Stock Institutional Investors

Note, although Shuttle Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Shuttle Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.81 M.

Shuttle Profitablity

Management Efficiency

Shuttle Pharmaceuticals has return on total asset (ROA) of (0.4717) % which means that it has lost $0.4717 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5202) %, meaning that it created substantial loss on money invested by shareholders. Shuttle Pharmaceuticals' management efficiency ratios could be used to measure how well Shuttle Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.16. The Shuttle Pharmaceuticals' current Return On Capital Employed is estimated to increase to -1.14. As of now, Shuttle Pharmaceuticals' Net Tangible Assets are increasing as compared to previous years. The Shuttle Pharmaceuticals' current Total Current Assets is estimated to increase to about 5.9 M, while Other Assets are projected to decrease to 5,184.

Technical Drivers

As of the 10th of June, Shuttle Pharmaceuticals has the Risk Adjusted Performance of 0.0471, coefficient of variation of 1607.96, and Semi Deviation of 2.72. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Shuttle Pharmaceuticals, as well as the relationship between them.

Shuttle Pharmaceuticals Price Movement Analysis

Shuttle Pharmaceuticals Insider Trading Activities

Shuttle Pharmaceuticals Predictive Daily Indicators

Shuttle Pharmaceuticals Forecast Models

Shuttle Pharmaceuticals' time-series forecasting models are one of many Shuttle Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Shuttle Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Shuttle Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Shuttle shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Shuttle Pharmaceuticals. By using and applying Shuttle Stock analysis, traders can create a robust methodology for identifying Shuttle entry and exit points for their positions.

When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.